<DOC>
	<DOCNO>NCT02598115</DOCNO>
	<brief_summary>The primary objective study evaluate impact implementation collaborative pharmaceutical care drug support admission patient 65 year age old . This cluster-randomized study stepped-wedge design . Clusters correspond participate center . A randomly select center crossed-over intervention every fifteen day start inclusion .</brief_summary>
	<brief_title>Impact Collaborative Pharmaceutical Care Hospital Admission Drug Prescriptions Patients 65 Years Age Older</brief_title>
	<detailed_description>The secondary objective evaluate : A . The potential observed clinical impact implementation collaborative pharmaceutical care . B . The acceptance rate pharmaceutical intervention collaborative pharmaceutical care . C. Avoidable cost related consumption care generate occurrence serious adverse drug reaction . D. The satisfaction health professional concern transfer information patient 's drug therapy carry part collaborative pharmaceutical care .</detailed_description>
	<criteria>The patient his/her legal representative inform study The patient admit inpatient one participating hospitals The patient available 3 month followup The subject participate another drug study The subject judicial protection It impossible correctly inform patient his/her legal representative The patient his/her legal representative refuse participate study The expected life span patient le require 3 month followup It impossible contact patient hospitalisation Hospitalizatin longer 21 day</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>collaborative pharmaceutical care</keyword>
</DOC>